Data & Technology

Campus will feature a CDMO, over 1,000,000 square feet of floor space

Not quite specialty, not quite retail: Cost-effective access and support strategies for a growing, yet underserved, treatment market

Leaders from Janssen, Novartis Gene Therapies, Pierre Fabre, and the German cancer app start-up Mika discuss how they are leveraging data in innovative ways to advance their engagement with the scientific community and their overall commercial operations

Pharma compliance requires stringent quality assurance in order to ensure patient safety, but the default for many pharma companies is still to use manual processes for supplier vetting and reporting. Gaëlle Jaron looks at how the food industry might inspire pharma to transform its processes

Product is powered by company’s Opus platform

Reportedly provides 270 hours of independent runtime for temperature-sensitive pharma transportation

What does digital innovation actually mean and how is it changing the way that pharma is interacting with HCPs and patients?

To unlock the full potential of new patient support tools, pharma companies must recognize the crucial role advanced analytics plays in facilitating enhanced patient engagement that yields improved adherence.

Aims to increase presence in affordability market

How CDMOs will lead the way toward true cloud lab enablement

Crēdo ProEnvision Software 2.0, company says, expected to improve the customer experience for cold chain clients

Among benefits, Expanded Access software can reportedly help design more effective clinical trials and capture RWD

Small and emerging biopharma have been historically reserved about artificial intelligence. But, writes Alan Kalton, AI solutions have matured, been proven, and are no longer a risky investment for small to mid-size companies.

Taking advantage of new advances in tech-driven engagement to boost patient support and adherence

Questions to ask before transitioning into new technologies. By Yvonne Duckworth and Cory Perelman.

GTS improvements include additional data integrity protection, greater Level 1 and 2 equipment compatibility

Agreement provides pharma firms with an RWD and commercialization solution

Can technology really build trust in pharmaceutical supply chains?

Quris’s system can help predict clinical safety, AI firm notes

Software firm merges with PharmaLex Group

A sit-down with members of the Deloitte team, who discuss the findings of the company’s yearly research and development report

Merger with Phlexglobal expands provider’s technological capabilities

Integrated system intends to accelerate enrollment by strengthening relationship between hub patient services and providers

Partnership looks to ensure that chargebacks for suppliers are as accurate as possible

Companies to focus on market access strategies